Both sides are claiming victory after Federal Judge Sarah Evans Barker’s ruling Friday in Eli Lilly’s lawsuit against HHS and HRSA.

340B Stakeholders Size Up Friday’s Mixed Decision in Lilly’s 340B Contract Pharmacy Lawsuit

Both sides are claiming victory after a federal judge’s ruling Friday in Eli Lilly’s lawsuit against federal health agencies in defense of its policies on 340B pricing when covered entities use contract pharmacies.

U.S. Senior Judge’s Sarah Evans Barker ruled on Oct. 29 that the U.S. Health Resources and Services Administration’s (HRSA) May 17 letter telling Lilly its contract pharmacy actions “have resulted in overcharges and are in direct violation of the 340B statute” was arbitrary and capricious in violation of the Administrative Procedure Act (APA).

340B stakeholders are still digesting a federal district judge’s ruling Friday in drug manufacturer Eli Lilly’s lawsuit against federal health agencies in defense of its policies on 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer